Dallah Healthcare Company (4004.SR)
SAR 125.6
(-1.88%)
SAR 125.6
(-1.88%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 224.08 Million SAR | -12.2% |
| 2022 | 255.23 Million SAR | 16.44% |
| 2021 | 219.2 Million SAR | 32.29% |
| 2020 | 165.69 Million SAR | 58.51% |
| 2019 | 104.53 Million SAR | 17.76% |
| 2018 | 88.77 Million SAR | 11.06% |
| 2017 | 79.93 Million SAR | 15.59% |
| 2016 | 69.14 Million SAR | -21.4% |
| 2015 | 87.98 Million SAR | -6.99% |
| 2014 | 94.59 Million SAR | 61.83% |
| 2013 | 58.45 Million SAR | 73.14% |
| 2012 | 33.76 Million SAR | 10.88% |
| 2011 | 30.44 Million SAR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 258.1 Million SAR | 14.72% |
| 2024 Q1 | 224.98 Million SAR | 0.4% |
| 2023 Q4 | 224.08 Million SAR | 5.89% |
| 2023 FY | 224.08 Million SAR | -12.2% |
| 2023 Q3 | 211.61 Million SAR | -9.38% |
| 2023 Q1 | 247.86 Million SAR | -2.89% |
| 2023 Q2 | 233.52 Million SAR | -5.79% |
| 2022 Q4 | 255.23 Million SAR | 2.91% |
| 2022 Q1 | 226.12 Million SAR | 3.16% |
| 2022 Q3 | 248 Million SAR | 3.14% |
| 2022 FY | 255.23 Million SAR | 16.44% |
| 2022 Q2 | 240.45 Million SAR | 6.34% |
| 2021 Q3 | 224.58 Million SAR | 11.7% |
| 2021 Q1 | 184.16 Million SAR | 11.15% |
| 2021 FY | 219.2 Million SAR | 32.29% |
| 2021 Q2 | 201.06 Million SAR | 9.18% |
| 2021 Q4 | 219.2 Million SAR | -2.4% |
| 2020 Q1 | 114.16 Million SAR | 9.21% |
| 2020 Q2 | 112.92 Million SAR | -1.08% |
| 2020 Q3 | 125.83 Million SAR | 11.43% |
| 2020 FY | 165.69 Million SAR | 58.51% |
| 2020 Q4 | 165.69 Million SAR | 31.67% |
| 2019 Q2 | 86.91 Million SAR | -10.37% |
| 2019 FY | 104.53 Million SAR | 17.76% |
| 2019 Q4 | 104.53 Million SAR | 19.2% |
| 2019 Q3 | 87.69 Million SAR | 0.9% |
| 2019 Q1 | 96.96 Million SAR | 9.23% |
| 2018 Q1 | 82.82 Million SAR | 3.62% |
| 2018 FY | 88.77 Million SAR | 11.06% |
| 2018 Q4 | 88.77 Million SAR | 26.99% |
| 2018 Q3 | 69.9 Million SAR | -4.34% |
| 2018 Q2 | 73.07 Million SAR | -11.78% |
| 2017 Q3 | 73.59 Million SAR | -12.61% |
| 2017 Q1 | 80.96 Million SAR | 17.08% |
| 2017 Q4 | 79.93 Million SAR | 8.62% |
| 2017 FY | 79.93 Million SAR | 15.59% |
| 2017 Q2 | 84.21 Million SAR | 4.01% |
| 2016 Q3 | 73.26 Million SAR | -16.5% |
| 2016 FY | 69.14 Million SAR | -21.4% |
| 2016 Q2 | 87.74 Million SAR | -1.8% |
| 2016 Q1 | 89.35 Million SAR | 1.56% |
| 2016 Q4 | 69.14 Million SAR | -5.62% |
| 2015 Q3 | 101.9 Million SAR | -10.21% |
| 2015 Q4 | 87.98 Million SAR | -13.67% |
| 2015 FY | 87.98 Million SAR | -6.99% |
| 2015 Q1 | 117.63 Million SAR | 24.36% |
| 2015 Q2 | 113.49 Million SAR | -3.52% |
| 2014 Q2 | 71.93 Million SAR | 4.52% |
| 2014 FY | 94.59 Million SAR | 61.83% |
| 2014 Q1 | 68.82 Million SAR | 17.75% |
| 2014 Q3 | 82.25 Million SAR | 14.35% |
| 2014 Q4 | 94.59 Million SAR | 14.99% |
| 2013 Q1 | 56.75 Million SAR | 68.11% |
| 2013 Q2 | 60.01 Million SAR | 5.74% |
| 2013 Q3 | 56.01 Million SAR | -6.66% |
| 2013 FY | 58.45 Million SAR | 73.14% |
| 2013 Q4 | 58.45 Million SAR | 4.35% |
| 2012 FY | 33.76 Million SAR | 10.88% |
| 2012 Q4 | 33.76 Million SAR | -10.63% |
| 2012 Q3 | 37.77 Million SAR | 0.0% |
| 2011 FY | 30.44 Million SAR | 0.0% |
| 2011 Q4 | 30.44 Million SAR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Mouwasat Medical Services Company | 197.16 Million SAR | -13.654% |
| National Medical Care Company | 59.91 Million SAR | -274.025% |
| Al Hammadi Company For Development and Investment | 56.59 Million SAR | -295.97% |
| Middle East Healthcare Company | 122.4 Million SAR | -83.064% |
| Dr. Sulaiman Al Habib Medical Services Group Company | 569.56 Million SAR | 60.657% |
| Canadian General Medical Center Complex Company | 1.91 Million SAR | -11573.554% |
| Arabian International Healthcare Holding Company | 250.93 Million SAR | 10.698% |
| Future Care Trading Co. | 1.00 SAR | -22408518800.0% |
| Naba Alsaha Medical Services Company | 12.01 Million SAR | -1764.345% |
| Lana Medical Co. | 5.75 Million SAR | -3793.559% |
| Al-Modawat Specialized Medical Co. | 3.92 Million SAR | -5611.157% |